BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Bevacizumab
1
Investigating radiotherapy’s impact on intestinal perforation risk in gastrointestinal tumor patients treated with bevacizumab
12/11/2025 8:20:56 AM | Browse: 36 | Download: 163
2
Clinical observation of combined transarterial chemoembolization and targeted therapy in postoperative recurrent colorectal cancer with liver metastasis
8/25/2025 12:36:25 PM | Browse: 161 | Download: 494
3
Two treatment methods for hepatocellular carcinoma: Lenvatinib or bevacizumab combined with sintilimab and interventional therapy
2/26/2025 4:21:32 AM | Browse: 125 | Download: 480
4
Atezolizumab and bevacizumab combination in advanced hepatocellular carcinoma patients: The imperative for safety assessment studies
12/12/2024 7:29:58 AM | Browse: 101 | Download: 462
5
Vascular endothelial growth factor pathway’s influence on bevacizumab efficacy in metastatic colorectal cancer treatment
10/25/2024 10:27:31 AM | Browse: 120 | Download: 496
6
Clinical evaluation of sintilimab in conjunction with bevacizumab for advanced colorectal cancer with microsatellite stable-type after failure of first-line therapy
9/28/2024 4:34:28 AM | Browse: 153 | Download: 793
7
Efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer according to programmed cell death ligand 1
8/8/2024 4:58:16 AM | Browse: 191 | Download: 719
8
Fatal intratumoral hemorrhage in a patient with hepatocellular carcinoma following successful treatment with atezolizumab/bevacizumab: A case report
7/2/2024 8:41:38 AM | Browse: 124 | Download: 670
9
Hepatocellular carcinoma immune microenvironment and check point inhibitors-current status
3/27/2024 1:28:19 PM | Browse: 125 | Download: 376
10
Chemotherapy combined with bevacizumab for small cell lung cancer with brain metastases: A case report
1/11/2024 5:28:10 AM | Browse: 205 | Download: 1160
11
Evaluating combined bevacizumab and XELOX in advanced colorectal cancer: Serum markers carcinoembryonic antigen, carbohydrate antigen (CA) 125, CA199 analysis
1/2/2024 9:08:46 AM | Browse: 221 | Download: 1263
12
Efficacy and safety of anti-vascular endothelial growth factor agents on corneal neovascularization: A meta-analysis
10/25/2023 8:49:11 AM | Browse: 348 | Download: 1133
13
Massive bleeding from a gastric artery pseudoaneurysm in hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A case report
6/15/2023 12:09:46 PM | Browse: 367 | Download: 1078
14
Treatment outcome analysis of bevacizumab combined with cyclophosphamide and oxaliplatin in advanced pseudomyxoma peritonei
6/15/2023 12:09:45 PM | Browse: 194 | Download: 994
15
Retrospective efficacy analysis of olaparib combined with bevacizumab in the treatment of advanced colorectal cancer
5/26/2023 9:50:16 AM | Browse: 289 | Download: 1325
16
Systemic treatment for unresectable hepatocellular carcinoma
3/10/2023 7:29:15 AM | Browse: 295 | Download: 846
17
Synaptophysin-like 2 expression correlates with lymph node metastasis and poor prognosis in colorectal cancer patients
11/15/2022 10:19:35 AM | Browse: 601 | Download: 2083
18
Safety of endoscopy in patients undergoing treatments with antiangiogenic agents: A 5-year retrospective review
7/14/2022 8:05:03 AM | Browse: 674 | Download: 1898
19
Arteriovenous thrombotic events in a patient with advanced lung cancer following bevacizumab plus chemotherapy: A case report
6/24/2022 9:00:24 AM | Browse: 581 | Download: 1603
20
Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice
9/22/2021 8:09:41 AM | Browse: 648 | Download: 1060
21
Colorectal cancer metastatic to the breast: A case report
9/10/2020 5:57:28 AM | Browse: 913 | Download: 1773
22
Mechanisms and anatomical risk factors of pneumothorax after Bevacizumab use: A case report
7/20/2020 2:28:50 AM | Browse: 914 | Download: 2225
23
Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports
4/28/2020 8:04:31 AM | Browse: 1001 | Download: 1827
24
Primary tumor location and survival in colorectal cancer: A retrospective cohort study
4/15/2020 12:00:00 PM | Browse: 944 | Download: 1983
25
Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy
2/22/2019 4:33:37 AM | Browse: 1193 | Download: 1443
26
Tertiary stent-in-stent for obstructing colorectal cancer: A case report and literature review
1/16/2019 8:39:45 AM | Browse: 1018 | Download: 2029
27
Considering FOLFOXIRI plus bevacizumab for metastatic colorectal cancer with left-sided tumors
12/14/2018 10:51:23 AM | Browse: 1006 | Download: 1474
28
CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer
11/13/2018 8:04:45 AM | Browse: 1229 | Download: 2034
29
Bevacizumab and gastrointestinal bleeding in hereditary hemorrhagic telangiectasia
12/20/2016 1:38:00 PM | Browse: 1356 | Download: 2396
30
Role of targeted therapy in metastatic colorectal cancer
9/12/2016 10:43:00 AM | Browse: 1253 | Download: 2190
31
Treatment of diabetic retinopathy: Recent advances and unresolved challenges
8/23/2016 8:55:00 AM | Browse: 1279 | Download: 2185
32
Total and not bevacizumab-bound vascular endothelial growth factor as potential predictive factors to bevacizumab-based chemotherapy in colorectal cancer
7/15/2016 3:38:00 PM | Browse: 1434 | Download: 2356
33
Molecular pathogenesis of glioblastoma multiforme: Nuances, obstacles, and implications for treatment
9/30/2015 4:28:00 PM | Browse: 1499 | Download: 2116
34
Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study
6/20/2015 5:38:00 PM | Browse: 1666 | Download: 3313
35
Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab
5/13/2015 10:38:00 AM | Browse: 1310 | Download: 2791
36
Value of bevacizumab in treatment of colorectal cancer: A meta-analysis
4/27/2015 4:29:00 PM | Browse: 1390 | Download: 2108
37
Targeted therapy in first line treatment of RAS wild type colorectal cancer
3/16/2015 6:04:00 PM | Browse: 1292 | Download: 1789
38
FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma
2/11/2015 4:38:00 PM | Browse: 1215 | Download: 1416
39
Combinations of vascular endothelial growth factor pathway inhibitors with metronomic chemotherapy: Rational and current status
11/19/2014 2:49:00 PM | Browse: 1310 | Download: 1667
40
Bevacizumab maintenance in metastatic colorectal cancer: How long?
11/10/2014 12:19:00 PM | Browse: 1241 | Download: 1837
41
Preoperative intravitreal bevacizumab and silicone oil tamponade for vitrectomy in diabetic retinopathy
10/20/2014 9:54:00 AM | Browse: 1308 | Download: 2027
42
Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases
9/16/2014 6:10:00 PM | Browse: 1365 | Download: 1351
43
Role of bevacizumab in colorectal cancer growth and its adverse effects: A review
9/15/2014 8:54:00 PM | Browse: 1401 | Download: 1462
44
Anti-angiogenic therapies for metastatic colorectal cancer: Current and future perspectives
9/11/2014 8:40:00 PM | Browse: 1223 | Download: 1766
45
Meta-regression of treatments for metastatic colorectal cancer: Quantifying incremental benefit from 2000 to 2012
9/3/2014 11:44:00 AM | Browse: 1323 | Download: 1793
46
Bevacizumab for the management of diabetic macular edema
9/1/2014 3:42:00 PM | Browse: 1339 | Download: 1351
47
Ranibizumab in diabetic macular edema
9/1/2014 2:50:00 PM | Browse: 1309 | Download: 1487
48
Molecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer
9/1/2014 10:30:00 AM | Browse: 1494 | Download: 1203
49
Targeting receptor tyrosine kinases in gastric cancer
8/28/2014 5:50:00 PM | Browse: 1313 | Download: 1561
50
Bevacizumab in the pre-operative treatment of locally advanced rectal cancer: A systematic review
8/26/2014 5:16:00 PM | Browse: 1368 | Download: 1243